SAR of a series of inhaled A2A agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data

被引：24

作者：

Mantell, Simon J. ^{[1
]}

Stephenson, Peter T. ^{[1
]}

Monaghan, Sandra M. ^{[1
]}

Maw, Graham N. ^{[1
]}

Trevethick, Michael A. ^{[1
]}

Yeadon, Michael ^{[1
]}

Walker, Don K. ^{[1
]}

Selby, Matthew D. ^{[1
]}

Batchelor, David V. ^{[1
]}

Rozze, Stuart ^{[1
]}

Chavaroche, Helene ^{[1
]}

Lemaitre, Arnaud ^{[1
]}

Wright, Karen N. ^{[1
]}

Whitlock, Lynsey ^{[1
]}

Stuart, Emilio F. ^{[1
]}

Wright, Patricia A. ^{[1
]}

Macintyre, Fiona ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Sandwich Labs, Sandwich CT13 9NJ, Kent, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 15期

关键词：

A2A; COPD; Pharmacokinetics; Inhalation; OBSTRUCTIVE PULMONARY-DISEASE; RECEPTOR AGONIST; INFLAMMATION; THERAPY;

D O I：

10.1016/j.bmcl.2009.05.027

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

COPD is a major cause of mortality in the western world. A(2A) agonists are postulated to reduce the lung inflammation that causes COPD. The cardiovascular effects of A(2A) agonists dictate that a compound needs to be delivered by inhalation to be therapeutically useful. The pharmacological and pharmacokinetic SAR of a series of inhaled A(2A) agonists is described leading through to human pharmacokinetic data for a clinical candidate. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：4471 / 4475

页数：5

共 50 条

[31] CONTROVERSIES IN RESPIRATORY MEDICINE - REGULAR INHALED BETA-AGONISTS - CLEAR CLINICAL BENEFIT OR A HAZARD TO HEALTH .2. WHY BETA-AGONISTS SHOULD NOT BE USED REGULARLY
PAGE, C
COSTELLO, J
RESPIRATORY MEDICINE, 1992, 86 (06) : 477 - 479
[32] Combination inhalers containing inhaled corticosteroids and long-acting β2-agonists:: Improved clinical efficacy and dosing options in patients with asthma
Ankerst, J
JOURNAL OF ASTHMA, 2005, 42 (09) : 715 - 724
[33] Comparison of Formoterol, Glycopyrrolate, and Beclomethasone Dipropionate Pharmacokinetic Profile after Inhaled Administration as pMDI Using HFA134a or HFA152a Propellant: Preclinical Assessment of Drug Exposure in Sprague-Dawley Rat Model
Fioni, Alessandro
Brogin, Giandomenico
Puccini, Paola
Allen, Andrew Dennis
Miglietta, Daniela
Cuoghi, Erika
Zambelli, Enrico
Battipaglia, Loredana
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2025, 38 (01) : 18 - 25
[34] Clinical Pharmacokinetics and Tolerability of AZD3199, a New Inhaled Ultra Long-acting β2-adrenoreceptor Agonist (uLABA) Bronchodilator
Kuna, P.
Rosenborg, J.
Bengtsson, T.
Jorup, C.
Bjermer, L.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB76 - AB76
[35] A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β2-Agonists
Wolthers, Ole D.
Shah, Tushar
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (03) : 182 - 188
[36] A toxicokinetic study of inhaled ethylene glycol monomethyl ether (2-ME) and validation of a physiologically based pharmacokinetic model for the pregnant rat and human
Gargas, ML
Tyler, TR
Sweeney, LM
Corley, RA
Weitz, KK
Mast, TJ
Paustenbach, DJ
Hays, SM
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 165 (01) : 53 - 62
[37] A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F(1) mice, F344 rats, and humans
Pastino, GM
Asgharian, B
Roberts, K
Medinsky, MA
Bond, JA
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 145 (01) : 147 - 157
[38] A Holy Grail of asthma management:: toward understanding how long-acting β2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
Giembycz, M. A.
Kaur, M.
Leigh, R.
Newton, R.
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (06) : 1090 - 1104
[39] Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: application to development PBPK model in rats
Mihye Kwon
Jung Bae Park
Miwha Kwon
Jinho Song
Chang Su Yeo
Soo Hyeon Bae
Archives of Toxicology, 2021, 95 : 2019 - 2036
[40] Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: application to development PBPK model in rats
Kwon, Mihye
Park, Jung Bae
Kwon, Miwha
Song, Jinho
Yeo, Chang Su
Bae, Soo Hyeon
ARCHIVES OF TOXICOLOGY, 2021, 95 (06) : 2019 - 2036

← 1 2 3 4 5 →